Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (271-280 of 325) with videos related to

Pageof 33
Sort By:
Current Oncology (Toronto, Ont.)|May 15, 2023
Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)Lisa Bloudek, Phoebe Wright, Caroline McKay, et al.
Journal of the American Medical Informatics Association : JAMIA|January 13, 2010
The impact of computerized provider order entry on medication errors in a multispecialty group practiceEmily Beth Devine, Ryan N Hansen, Jennifer L Wilson-Norton, et al.
JCO Oncology Practice|October 3, 2023
Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF PrescribingDawn L Hershman, Aasthaa Bansal, William E Barlow, et al.
The Annals of Pharmacotherapy|April 30, 2002
Lipid-lowering drug use and cardiovascular events after myocardial infarctionOlaf H Klungel, Susan R Heckbert, Anthonius de Boer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 22, 2013
Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims databaseBrian S Seal, Sean D Sullivan, Scott D Ramsey, et al.
Journal of Managed Care & Specialty Pharmacy|December 7, 2023
Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United StatesRickard Sandin, David L Veenstra, Mathilde Vankelegom, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2008
The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003Adrian R Levy, Boris Sobolev, Douglas James, et al.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
International Journal of Breast Cancer|August 16, 2016
Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast CancerElizabeth Trice Loggers, Diana S M Buist, Laura S Gold, et al.
Journal of Clinical Epidemiology|December 25, 2004
Methods to assess intended effects of drug treatment in observational studies are reviewedOlaf H Klungel, Edwin P Martens, Bruce M Psaty, et al.
Pageof 33

Showing results (271-280 of 325) with videos related to

Sort By:
Pageof 33
Current Oncology (Toronto, Ont.)|May 15, 2023
Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)Lisa Bloudek, Phoebe Wright, Caroline McKay, et al.
Journal of the American Medical Informatics Association : JAMIA|January 13, 2010
The impact of computerized provider order entry on medication errors in a multispecialty group practiceEmily Beth Devine, Ryan N Hansen, Jennifer L Wilson-Norton, et al.
JCO Oncology Practice|October 3, 2023
Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF PrescribingDawn L Hershman, Aasthaa Bansal, William E Barlow, et al.
The Annals of Pharmacotherapy|April 30, 2002
Lipid-lowering drug use and cardiovascular events after myocardial infarctionOlaf H Klungel, Susan R Heckbert, Anthonius de Boer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 22, 2013
Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims databaseBrian S Seal, Sean D Sullivan, Scott D Ramsey, et al.
Journal of Managed Care & Specialty Pharmacy|December 7, 2023
Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United StatesRickard Sandin, David L Veenstra, Mathilde Vankelegom, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2008
The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003Adrian R Levy, Boris Sobolev, Douglas James, et al.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
International Journal of Breast Cancer|August 16, 2016
Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast CancerElizabeth Trice Loggers, Diana S M Buist, Laura S Gold, et al.
Journal of Clinical Epidemiology|December 25, 2004
Methods to assess intended effects of drug treatment in observational studies are reviewedOlaf H Klungel, Edwin P Martens, Bruce M Psaty, et al.
Pageof 33